There was a 3-fold defect in the frequency of CD69/CD103 double-positive cells among S- and N-specific CD4 T cells in the BAL at 4–5 weeks post-infection in the anti-IL-10 treatment group relative to controls (Fig 6B). The gene discussed is CD69; the disease is infection.